文献速递血栓与止血

国际儿童血友病管理网络登记中B型血友病Leyden型:特征与自然史

Hemophilia B Leyden: characteristics and natural history in the International Pediatric Network of Hemophilia Management Registry.
PubMed 文献 · J Thromb Haemost · 2024-12-30

该研究基于国际儿童血友病管理网络登记(PedNet)数据库,纳入2000年后出生的儿童血友病患者,评估B型血友病Leyden型的自然史、基因型-表型关联、因子IX水平变化、出血表型及治疗。457例B型血友病患者中24例携带Leyden型基因型,最常见的变异为c.-35G>A(14例),其因子IX水平在4岁前升高但未随时间正常化,出血率低,与非c.-35G>A变异者的表型不同。

要点

  • 457例B型血友病中24例为Leyden型,c.-35G>A最常见(14例)。
  • c.-35G>A者4岁前因子IX升高但未正常化,出血率低。
  • 非c.-35G>A者因子IX升高较少(4/9)且出现较晚。

核心结论

  • B型血友病Leyden型在超过50%的病例中由c.-35G>A变异引起,该变异者因子IX在很小年龄即升高,与低出血率相关,与携带非c.-35G>A变异者的表型不同。
  • 该研究可能有助于指导这一罕见B型血友病实体的临床决策。

研究设计与样本

  • 研究从国际儿童血友病管理网络登记(PedNet)数据库中提取2000年后出生的儿童血友病患者数据,分析基因变异、诊断时及随时间变化的因子IX水平、出血和治疔详情。

主要发现

  • 457例B型血友病患者中24例显示Leyden型基因型,最常见的F9变异为c.-35G>A(14例),其次为c.-35G>C(4例)、c.-49T>A(2例),以及c.-52C>T、c.-34A>G和c.-22delT各1例。
  • 比较c.-35G>A与非c.-35G>A基因型时,观察到出血和治疔方式的重大临床差异。
  • 所有携带c.-35G>A基因型的儿童,因子IX水平在4岁前升高,但未随时间正常化,无论初始严重程度如何。
  • 携带非c.-35G>A基因型的儿童中,因子IX升高较少见(4/9)且出现较晚。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A unique form of hemophilia B (HB) is HB Leyden. We evaluated the international Pediatric Network on Hemophilia Management Registry (PedNet) database to explore the natural history of HB Leyden, investigate genotype-phenotype associations, and guide clinical decision-making. OBJECTIVES: To assess the association between genetic variants, endogenous factor (F)IX levels over time, treatment, and bleeding phenotype in children with HB Leyden. METHODS: Data on genetic variants, FIX levels at diagnosis and over time, bleeding, and treatment details were extracted from the international PedNet in children with hemophilia born since 2000. RESULTS: Of 457 individuals with HB, 24 showed an HB Leyden genotype. The most frequent F9 variant was c.-35G>A, affecting 14 individuals, followed by c.-35G>C (n = 4), c.-49T>A (n = 2), and c.-52C>T, c.-34A>G, and c.-22delT (n = 1 each). Major clinical differences in bleeding and treatment modality were observed when comparing c.-35G>A with non-c.-35G>A genotypes. For all children with a c.-35G>A genotype, FIX levels increased before the age of 4 years but did not normalize over time, irrespective of initial severity. In children with non-c.-35G>A genotypes, an increase in FIX was less common (4/9) and occurred later. CONCLUSION: HB Leyden is caused by the variant c.-35G>A in >50% of cases in whom a FIX increase occurs at very young ages, which is associated with low bleeding rates. This contrasts with the phenotype of individuals with HB Leyden due to a non-c.-35G>A variant. Our study may thus help guide clinical decision-making in this rare HB entity.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Kartal-Kaess M, Pinto F, Labarque V, et al. Hemophilia B Leyden: characteristics and natural history in the International Pediatric Network of Hemophilia Management Registry. J Thromb Haemost. 2024. PMID: 39742973. doi:10.1016/j.jtha.2024.12.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。